UCB SA - BNP Paribas Fortis

Development Cooperation in the Belgian Federal Government. Armand De Decker is currently Mayor
of Uccle (a commune of Brussels) and has been re-elected President of the Senate on 12 July 2007.
Armand De Decker has received numerous special recognitions from many countries (among others,
Belgium, France, Spain, Sweden, Finland, Denmark, Italy, Mexico) and has various mandates in
organisations such as Alzheimer Belgique (the Belgian Alzheimer’s association), the Belgian Royal
Institute of International Relations, and the Belgian Reference Centre for Expertise on Central Africa.
Peter Fellner was appointed to the Board in 2005. Peter Fellner is chairman of Vernalis plc, and of the
privately held UK biotechnology company, Astex Therapeutics Ltd. He is also a director of Qinetiq
Group plc, Evotec AG, and Consort Medical plc (previously Bespak plc). He was previously chairman
of Celltech Group plc, having served as its chief executive officer from 1990 to 2003. He oversaw its
development into the UK’s largest biotechnology company, until its acquisition by the Issuer in 2004.
Before joining Celltech, he served as chief executive officer of Roche UK, from 1986 to 1990. From
1984 to 1986 he was director of the Roche UK Research Centre.
Jean-Pierre Kinet has been a member of the Board since 2008. He holds a medical degree (MD) from
the University of Liège (ULg, Belgium). He is a professor of pathology at Harvard Medical School and
at the Beth Israel Deaconess Medical Center in Boston (U.S.). He is a member of numerous Harvard,
U.S. and international committees such as National Institutes of Health (NIH) expert panels and the
International Strategic Support Committee of Biowin (Health Cluster of Wallonia). He has extensive
experience in the research and development of novel therapies and is a board member of several
biotechnology companies.
Thomas Leysen has been a member of the Board since January 2009. He has been chairman of the
board of Umicore since 19 November 2008, and was previously chief executive officer of Umicore
from May 2000 until 19 November 2008. He holds a Master of Law Degree from the University of
Leuven (K.U.Leuven, Belgium). He started his career in the maritime business in Hamburg, London
and Tokyo. From 1983 to 1988, he managed the Transcor group, which he built into an international oil
and coal trading company with activities in Europe, America and Asia. He joined Umicore in 1993 as a
member of the Executive Committee, and successively managed several industrial divisions. He became
executive vice president of the company in 1998. Thomas Leysen is also chairman of the board of
Corelio, Belgium’s largest newspaper-publishing group, member of the board of CMB (Compagnie
Maritime Belge), Norddeutsche Affinerie, Etex Group as well as member of the supervisory board of
Bank Metzler in Frankfurt. He is chairman of FEB – VBO (Federation of Belgian Enterprises) and
former Chairman of Eurométaux (the European metals industry federation). He is also president of the
BJA (Belgium-Japan Association). He is a member of the Trilateral Commission and of the European
Round Table of Industrialists (ERT). In the cultural sphere, he is a member of the board of trustees of
the Rubens House Museum in Antwerp and is chairman of the Art Purchase Fund of the Fondation Roi
Baudouin.
Gerhard Mayr was appointed to the Board in 2005. A native of Austria, Gerhard Mayr received a
Master’s Degree in chemical engineering from the Swiss Federal Institute of Technology (Zurich,
Switzerland) in 1969, and an MBA from Stanford University (U.S.) in 1972. In March 2004, he retired
as executive vice-president of pharmaceutical operations at Eli Lilly & Company after 32 years of
service. He had been responsible for global pharmaceutical operations, and sales and marketing
worldwide at Lilly. Gerhard Mayr is a former chairman of both the International Executive Committee
and the Europe Committee of the Pharmaceutical Research Manufacturers of America. He was a board
member of the European Federation of the Pharmaceutical Industry from 1995 to 1997 and from 2000
to 2002. Gerhard Mayr is a member of the board of Lonza Group Ltd.
A11250830/2.25/23 Oct 2009 94